The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl ethyl(2-(3-methoxyphenyl)benzo[d]oxazol-5-yl)phosphinate ID: ALA4762738
PubChem CID: 162660448
Max Phase: Preclinical
Molecular Formula: C17H18NO4P
Molecular Weight: 331.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCP(=O)(OC)c1ccc2oc(-c3cccc(OC)c3)nc2c1
Standard InChI: InChI=1S/C17H18NO4P/c1-4-23(19,21-3)14-8-9-16-15(11-14)18-17(22-16)12-6-5-7-13(10-12)20-2/h5-11H,4H2,1-3H3
Standard InChI Key: FDJVGIRRTPMYQG-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
12.7352 -8.3741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7341 -9.1936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4421 -9.6026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4403 -7.9652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1489 -8.3705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1537 -9.1891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9338 -9.4376 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4111 -8.7724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9260 -8.1131 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0260 -9.6017 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
11.3186 -9.1925 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0254 -10.4189 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3174 -10.8269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6004 -10.1777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3878 -10.9668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2263 -8.7671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6385 -9.4740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4549 -9.4696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8601 -8.7589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4430 -8.0513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6279 -8.0593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8449 -7.3398 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6620 -7.3321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
2 10 1 0
10 11 2 0
10 12 1 0
12 13 1 0
10 14 1 0
14 15 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
8 16 1 0
20 22 1 0
22 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 331.31Molecular Weight (Monoisotopic): 331.0973AlogP: 4.07#Rotatable Bonds: 5Polar Surface Area: 61.56Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.20CX LogD: 3.20Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.66Np Likeness Score: -0.90
References 1. Chatzopoulou M,Emer E,Lecci C,Rowley JA,Casagrande AS,Moir L,Squire SE,Davies SG,Harriman S,Wynne GM,Wilson FX,Davies KE,Russell AJ. (2020) Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators., 11 (12): [PMID:33335663 ] [10.1021/acsmedchemlett.0c00405 ] 2. Chatzopoulou, Maria and 16 more authors. 2020-03-12 Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-trans-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid. [PMID:31599580 ] 3. Babbs, Arran and 19 more authors. 2020-07-23 2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy. [PMID:32551645 ] 4. Chatzopoulou, Maria and 12 more authors. 2020-12-10 Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators. [PMID:33335663 ]